September 18, 2024 by Cleveland Clinic Credit: CC0 Public DomainA clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that impacts more than one in 5,000 people worldwide. The trial, led by Keith McCrae, M.D., of Cleveland Clinic, was stopped early...
